Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01463384 · ClinicalTrials.gov registry record · Phase 2
Minocycline in Patients With Alzheimer's Disease
A Phase 2 study, sponsored by Huntington Medical Research Institutes.
- Completed
- Registry status
- Phase 2
- Development phase
- 13
- Enrollment target
NCT01463384 is a Phase 2 study that has completed, run by Huntington Medical Research Institutes. The registered enrollment target is 13 participants.
The verdict
NCT01463384, a Phase 2 study, has completed, sponsored by Huntington Medical Research Institutes.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 13 participants
- Enrollment target
Study Summary
Cognitively normal individuals, patients with Mild Cognitive Impairment (MCI) or Alzheimer's Disease (AD) will undergo clinical screening, neuropsychological tests, blood and urine analyses, quantitative magnetic resonance imaging (MRI) and proton (1H ) and carbon 13 (13C) magnetic resonance spectroscopy (MRS). Each individual will receive minocycline oral administration for 4 weeks initially, after which MRI, MRS and neuropsychological results will be recorded. If no adverse side effects occur, subjects will continue minocycline administration for an additional 5 months.
Interventions
- DRUG Minocycline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2011-09 |
| Est. Completion | 2012-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01463384
The ClinicalTrials.gov registry entry for NCT01463384 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Huntington Medical Research Institutes, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Minocycline is the first listed.
NCT01463384 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01463384 about?
NCT01463384 is a clinical study titled "Minocycline in Patients With Alzheimer's Disease". Cognitively normal individuals, patients with Mild Cognitive Impairment (MCI) or Alzheimer's Disease (AD) will undergo clinical screening, neuropsychological tests, blood and urine analyses, quantitative magnetic resonance imaging (MRI) and proton (1H ) and carbon 13 (13C) magnetic resonance spectro...
What is the current status of trial NCT01463384?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 13 participants. The study started on 2011-09. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01463384?
The interventions under investigation include: Minocycline (DRUG).
Who is sponsoring clinical trial NCT01463384?
This trial is sponsored by Huntington Medical Research Institutes, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.